中华生物医学工程杂志
中華生物醫學工程雜誌
중화생물의학공정잡지
CHINESE JOURNAL OF BIOMEDICAL ENGINEERING
2011年
5期
434-438
,共5页
宋广忠%石君帆%泮结超%漏磊君%李召东
宋廣忠%石君帆%泮結超%漏磊君%李召東
송엄충%석군범%반결초%루뢰군%리소동
结核分枝杆菌%融合基因%融合蛋白%纯化%免疫反应性
結覈分枝桿菌%融閤基因%融閤蛋白%純化%免疫反應性
결핵분지간균%융합기인%융합단백%순화%면역반응성
mycobacterium tuberculosis%Gene Fusion%Fusion Protein%Purification%Immunoreactivity
目的 构建结核分枝杆菌rPstS1-hspX (rph)融合基因及其原核表达载体pET-23b(+)-rPstS1-hspX[pET-23b(+)-rph],表达、纯化rPstS1-HspX (rPH)融合蛋白,并分析其免疫反应性.方法 采用基因拼接技术将PstS1和HspX编码基因通过多肽接头(GSGSG)的DNA序列进行连接,构建融合基因rph.将融合基因定向克隆入原核表达载体pET-23b(+),构建重组原核表达质粒pET-23b(+)-rph.将重组质粒转化大肠杆菌E.coli BL21 (DE3) pLysE感受态细胞,IPTG诱导融合蛋白表达.SDS-PAGE和Western印迹法鉴定其表达情况.用镍离子鳌合亲和层析柱纯化融合蛋白,Western印迹法初步评价融合蛋白的免疫反应性.结果 融合基因rph及其原核表达载体pET-23b (+)-rph构建成功.融合蛋白rPH主要以可溶性非包涵体形式表达,相对分子质量为51 000,表达量约占菌体总蛋白的23%.经亲和层析后得到了纯度达92%的融合蛋白.Western印迹证实融合蛋白能与结核病阳性血清发生特异性免疫反应.结论 成功构建了原核表达载体pET-23b(+)-rph,获得了rPH融合蛋白,为rPH融合蛋白在结核病诊断中的应用提供了依据.
目的 構建結覈分枝桿菌rPstS1-hspX (rph)融閤基因及其原覈錶達載體pET-23b(+)-rPstS1-hspX[pET-23b(+)-rph],錶達、純化rPstS1-HspX (rPH)融閤蛋白,併分析其免疫反應性.方法 採用基因拼接技術將PstS1和HspX編碼基因通過多肽接頭(GSGSG)的DNA序列進行連接,構建融閤基因rph.將融閤基因定嚮剋隆入原覈錶達載體pET-23b(+),構建重組原覈錶達質粒pET-23b(+)-rph.將重組質粒轉化大腸桿菌E.coli BL21 (DE3) pLysE感受態細胞,IPTG誘導融閤蛋白錶達.SDS-PAGE和Western印跡法鑒定其錶達情況.用鎳離子鼇閤親和層析柱純化融閤蛋白,Western印跡法初步評價融閤蛋白的免疫反應性.結果 融閤基因rph及其原覈錶達載體pET-23b (+)-rph構建成功.融閤蛋白rPH主要以可溶性非包涵體形式錶達,相對分子質量為51 000,錶達量約佔菌體總蛋白的23%.經親和層析後得到瞭純度達92%的融閤蛋白.Western印跡證實融閤蛋白能與結覈病暘性血清髮生特異性免疫反應.結論 成功構建瞭原覈錶達載體pET-23b(+)-rph,穫得瞭rPH融閤蛋白,為rPH融閤蛋白在結覈病診斷中的應用提供瞭依據.
목적 구건결핵분지간균rPstS1-hspX (rph)융합기인급기원핵표체재체pET-23b(+)-rPstS1-hspX[pET-23b(+)-rph],표체、순화rPstS1-HspX (rPH)융합단백,병분석기면역반응성.방법 채용기인병접기술장PstS1화HspX편마기인통과다태접두(GSGSG)적DNA서렬진행련접,구건융합기인rph.장융합기인정향극륭입원핵표체재체pET-23b(+),구건중조원핵표체질립pET-23b(+)-rph.장중조질립전화대장간균E.coli BL21 (DE3) pLysE감수태세포,IPTG유도융합단백표체.SDS-PAGE화Western인적법감정기표체정황.용얼리자오합친화층석주순화융합단백,Western인적법초보평개융합단백적면역반응성.결과 융합기인rph급기원핵표체재체pET-23b (+)-rph구건성공.융합단백rPH주요이가용성비포함체형식표체,상대분자질량위51 000,표체량약점균체총단백적23%.경친화층석후득도료순도체92%적융합단백.Western인적증실융합단백능여결핵병양성혈청발생특이성면역반응.결론 성공구건료원핵표체재체pET-23b(+)-rph,획득료rPH융합단백,위rPH융합단백재결핵병진단중적응용제공료의거.
Objective To construct the Mycobacterium tuberculosis rPstS1-hspX (rph) fusion gene and its prokaryotic expression vector pET-23b (+)-rpstS1-hspX [pET-23b (+)-rph],and to evaluate the immunoreactivity of the fusion protein PstS1-HspX [rPH ] after expression and purification.Methods The fusion gene rph was constructed using gene splicing of DNA fragment that encodes a short polypeptide liner (GSGSG),then cloned into the prokaryotic vector pET-23b(+) to generate a recombinant plasmid,pET-23b(+)-rph.The recombinant plasmid was transformed into E.coli BL21 (DE3) pLysE cells.The expression of the histidine-tagged (His-Tag) fusion protein was induced with isopropyl-β-thiogalactopyranoside (IPTG),and verified with SDS- PAGE and Western blot.The fusion protein was purified by nickel affinity chromatography and evaluated for immunoreactivity with Western blot.Results The fusion gene rph and its prokaryotic expression vector pET-23b (+)-rph were successfully constructed.The expressed 51 000 fusion protein mainly existed in soluble form,accounting for about 23% of total proteins in E.coli.After nickel affinity chromatography,the purity of rPH reached 92%.The immunoreactivity of rph to positive serum from tuberculosis patients was confirmed by Western blot.Conclusion The successful construction of prokaryotic expression vector pET-23b (+)-rph and expression of fusion protein rPH provides experimental evidence for use of rPH fusion protein in diagnosis of tuberculosis.